108 related articles for article (PubMed ID: 29173610)
1. Endothelial Nitric Oxide Synthase-Induced Hypertrophy and Vascular Dysfunction Contribute to the Left Ventricular Dysfunction in Caveolin-1
Ebner A; Kuerbis N; Brandt A; Zatschler B; Weinert S; Poitz DM; Ebner B; Augstein A; Wunderlich C; El-Armouche A; Strasser RH
Can J Cardiol; 2017 Dec; 33(12):1716-1724. PubMed ID: 29173610
[TBL] [Abstract][Full Text] [Related]
2. Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.
Ruetten H; Dimmeler S; Gehring D; Ihling C; Zeiher AM
Cardiovasc Res; 2005 Jun; 66(3):444-53. PubMed ID: 15914109
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.
Godo S; Sawada A; Saito H; Ikeda S; Enkhjargal B; Suzuki K; Tanaka S; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):97-107. PubMed ID: 26543099
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular diastolic dysfunction in Nrf2 knock out mice is associated with cardiac hypertrophy, decreased expression of SERCA2a, and preserved endothelial function.
Erkens R; Kramer CM; Lückstädt W; Panknin C; Krause L; Weidenbach M; Dirzka J; Krenz T; Mergia E; Suvorava T; Kelm M; Cortese-Krott MM
Free Radic Biol Med; 2015 Dec; 89():906-17. PubMed ID: 26475037
[TBL] [Abstract][Full Text] [Related]
5. Low-intensity pulsed ultrasound ameliorates cardiac diastolic dysfunction in mice: a possible novel therapy for heart failure with preserved left ventricular ejection fraction.
Monma Y; Shindo T; Eguchi K; Kurosawa R; Kagaya Y; Ikumi Y; Ichijo S; Nakata T; Miyata S; Matsumoto A; Sato H; Miura M; Kanai H; Shimokawa H
Cardiovasc Res; 2021 Apr; 117(5):1325-1338. PubMed ID: 32683442
[TBL] [Abstract][Full Text] [Related]
6. Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice.
Polanski AK; Ebner A; Ebner B; Hofmann A; Steinbronn N; Brandt A; Forkmann M; Tausche AK; Morawietz H; Strasser RH; Wunderlich C
J Cardiovasc Pharmacol; 2013 Jun; 61(6):545-52. PubMed ID: 23474841
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 modulates cardiac gap junction homeostasis and arrhythmogenecity by regulating cSrc tyrosine kinase.
Yang KC; Rutledge CA; Mao M; Bakhshi FR; Xie A; Liu H; Bonini MG; Patel HH; Minshall RD; Dudley SC
Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):701-10. PubMed ID: 25017399
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of endothelial nitric oxide synthase and caveolin-1 in the aorta of rats with isoproterenol-induced cardiac hypertrophy.
Krenek P; Klimas J; Kroslakova M; Gazova A; Plandorova J; Kucerova D; Fecenkova A; Svec P; Kyselovic J
Can J Physiol Pharmacol; 2006 Dec; 84(12):1245-50. PubMed ID: 17487232
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation.
Ramírez CM; Zhang X; Bandyopadhyay C; Rotllan N; Sugiyama MG; Aryal B; Liu X; He S; Kraehling JR; Ulrich V; Lin CS; Velazquez H; Lasunción MA; Li G; Suárez Y; Tellides G; Swirski FK; Lee WL; Schwartz MA; Sessa WC; Fernández-Hernando C
Circulation; 2019 Jul; 140(3):225-239. PubMed ID: 31154825
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy.
Piech A; Massart PE; Dessy C; Feron O; Havaux X; Morel N; Vanoverschelde JL; Donckier J; Balligand JL
Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H219-31. PubMed ID: 11748066
[TBL] [Abstract][Full Text] [Related]
11. Normal and high eNOS levels are detrimental in both mild and severe cardiac pressure-overload.
van Deel ED; Octavia Y; de Boer M; Juni RP; Tempel D; van Haperen R; de Crom R; Moens AL; Merkus D; Duncker DJ
J Mol Cell Cardiol; 2015 Nov; 88():145-54. PubMed ID: 26436984
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
13. The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.
Wunderlich C; Schober K; Schmeisser A; Heerwagen C; Tausche AK; Steinbronn N; Brandt A; Kasper M; Schwencke C; Braun-Dullaeus RC; Strasser RH
J Mol Cell Cardiol; 2008 May; 44(5):938-47. PubMed ID: 18417152
[TBL] [Abstract][Full Text] [Related]
14. Atheroprotective role of Caveolin-1 and eNOS in an innovative transplantation model is mainly mediated by local effects.
Mierke J; Christoph M; Pfluecke C; Jellinghaus S; Wunderlich C; Strasser RH; Ibrahim K; Poitz DM
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):529-536. PubMed ID: 27915034
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells Expressing eNOS and a Cav1 Mutant Inhibit Vascular Smooth Muscle Cell Proliferation in a Rat Model of Pulmonary Hypertension.
Chen H; Yang H; Yue H; Strappe PM; Xia P; Pan L; Zhang Y; Chai S; Chen S; Ma L; Wang L
Heart Lung Circ; 2017 May; 26(5):509-518. PubMed ID: 27771236
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Endothelial (dys)Function, Left Ventricular Structure and Function in Patients with Chronic Kidney Disease.
Bartnicki P; Kowalczyk M; Franczyk-Skóra B; Baj Z; Rysz J
Curr Vasc Pharmacol; 2016; 14(4):360-7. PubMed ID: 26759218
[TBL] [Abstract][Full Text] [Related]
17. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.
Takimoto E; Champion HC; Li M; Ren S; Rodriguez ER; Tavazzi B; Lazzarino G; Paolocci N; Gabrielson KL; Wang Y; Kass DA
J Clin Invest; 2005 May; 115(5):1221-31. PubMed ID: 15841206
[TBL] [Abstract][Full Text] [Related]
18. Low-Intensity Pulsed Ultrasound Enhances Angiogenesis and Ameliorates Left Ventricular Dysfunction in a Mouse Model of Acute Myocardial Infarction.
Shindo T; Ito K; Ogata T; Hatanaka K; Kurosawa R; Eguchi K; Kagaya Y; Hanawa K; Aizawa K; Shiroto T; Kasukabe S; Miyata S; Taki H; Hasegawa H; Kanai H; Shimokawa H
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1220-9. PubMed ID: 27079882
[TBL] [Abstract][Full Text] [Related]
19. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
20. eNOS Activity in CAV1 Knockout Mouse Eyes.
Lei Y; Song M; Wu J; Xing C; Sun X
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2805-13. PubMed ID: 27228562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
